Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
129
days
Early warnings about the Galleri test were disregarded
Authors
Eleftherios P. DiamandisShow moreShow less
Affiliations
1. Lunenfeld-Tanenbaum Research Institute (LTRI), Sinai Health System, Mount Sinai Hospital, Toronto, CanadaShow moreShow less
84
days
MyeloTrak: a sequencing-independent mass spectrometry assay for blood-based residual M-protein monitoring in multiple myeloma
Authors
Po-Hsin Kong; Te-Lin Hsu; Yen-Chun Huang; Chun-Kuang Tsai; Chiu-Mei Yeh; Yow-Ling Shiue; Jocelyn Duen-Ya Jea; Laising Yen; Chen-Chung Liao; Chia-Jen LiuShow moreShow less
Affiliations
1. Marker X Co., Ltd, Taipei, Taiwan; 2. Institute of Biomedical Sciences, College of Medicine, National Sun Yat- Sen University, Kaohsiung, Taiwan; 3. Division of Transfusion Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; 4. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; 5. Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; 6. Department of Medicine, Kinmen Hospital, Ministry of Health and Welfare, Kinmen, Taiwan; 7. Division of Hematology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; 8. Curriculum Structure of Precision Electronic Components, College of Semiconductor and Advanced Technology Research, National Sun Yat- sen University, Kaohsiung, Taiwan; 9. Department of Pathology & Immunology, Baylor College of Medicine, Houston, USA; 10. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, USA; 11. Mass Spectrometry Facility, Instrumentation Resource Center, National Yang Ming Chiao Tung University, Taipei, Taiwan; 12. Cancer and Immunology Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan; 13. Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanShow moreShow less
81
days
Rebuttal to “Early Warnings About the Galleri Test Were Disregarded”
Authors
Eric A. Klein; Oliver Venn; Eric T. FungShow moreShow less
Affiliations
1. GRAIL, Inc., Sunnyvale, USAShow moreShow less
130
days
Circulating proteomic biomarkers of immune checkpoint inhibitor outcomes: a comprehensive pan-cancer review of pre-treatment cohorts
Authors
Theodoros Margelos; Aggeliki Tserga; Maria Frantzi; Antonia VlahouShow moreShow less
Affiliations
1. Center of Systems Biology, Biomedical Research Foundation, Academy of Athens, Athens, Greece; 2. Mosaiques Diagnostics GmbH, Hannover, GermanyShow moreShow less
24
days
Salivary proline-rich proteins are non-canonical serum biomarkers of chronic kidney disease
Authors
Satoshi Kozawa; Kyoji Urayama; Kengo Tejima; Mari Nakanishi; Yosuke Nakagawa; Masahiro Eriguchi; Makoto Watanabe; Takaaki Kosugi; Tadaaki Kirita; Kazuhiko Tsuruya; Yoshihiko Saito; Makoto Kuro-o; Thomas N. SatoShow moreShow less
Affiliations
1. Karydo TherapeutiX, Inc., Seika-cho, Soraku-gun, Kyoto, Japan; 2. The Thomas N. Sato BioMEC-X Laboratories, Advanced Telecommunications Research Institute International (ATR), Kyoto, Japan; 3. ERATO Sato-Live Bio-Forecasting Project, Kyoto, Japan; 4. V-iCliniX Laboratory, Nara Medical University (NMU), Nara, Japan; 5. Department of Oral and Maxillofacial Surgery, Nara Medical University (NMU), Nara, Japan; 6. Department of Nephrology, Nara Medical University (NMU), Nara, Japan; 7. Department of Cardiovascular Medicine, Nara Medical University (NMU), Nara, Japan; 8. Division of Mineral Metabolism, Center for Molecular Medicine, Jichi Medical University, Tochigi, JapanShow moreShow less
119
days
Scalable clinical proteomics from DNA/RNA extraction flowthroughs enables integrated proteogenomic profiling from a single cancer biopsy
Authors
Filip Mundt; Annelaura Bach Nielsen; Juanjuan Wang; Josephine Kerzel Duel; Christina Westmose Yde; Martina Amnitzbøll Eriksen; Ulrik Lassen; Finn Cilius Nielsen; Kristoffer Rohrberg; Matthias MannShow moreShow less
Affiliations
1. Proteomics Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark; 2. Department of Clinical Biochemistry Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; 3. Rigshospitalet, Copenhagen University Hospital , Denmark; 4. Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, GermanyShow moreShow less
FAQ
How long does Clinical Proteomics take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for Clinical Proteomics. The fastest paper went from submission to acceptance in 24 days (Salivary proline-rich proteins are non-canonical serum biomarkers of chronic kidney disease, received 2026-09-05, accepted 2026-09-29); the slowest took 340 days. The average is 113.9 days and the median is 94 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
